Multicomponent Therapy for Fibromyalgia

The Effect of a 12-week Multicomponent Therapy in Fibromyalgia

Therapy for fibromyalgia is a well discussed topic in literature, yet not thoroughly evidence-based. Several unicomponent therapies seem to be benificial. Whereas multicomponent and multidisciplinary therapy gains importance and revealing promising results, the investigators aim to combine two well-known therapies in a program for patients with fibromyalgia.

From clinical experience, a high drop-out rate has been stated. All data will be explored to analyse explanatory factors.

Inclusion Criteria:

• woman with fibromyalgia
• between the age of 20 and 50
• agreement with therapy protocol

Exclusion Criteria:

• high indication of depression measured with the Beck Depression Index